1. Home
  2. SAGE vs METC Comparison

SAGE vs METC Comparison

Compare SAGE & METC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • METC
  • Stock Information
  • Founded
  • SAGE 2010
  • METC 2015
  • Country
  • SAGE United States
  • METC United States
  • Employees
  • SAGE N/A
  • METC N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • METC Coal Mining
  • Sector
  • SAGE Health Care
  • METC Energy
  • Exchange
  • SAGE Nasdaq
  • METC Nasdaq
  • Market Cap
  • SAGE 444.1M
  • METC 509.5M
  • IPO Year
  • SAGE 2014
  • METC 2017
  • Fundamental
  • Price
  • SAGE $7.31
  • METC $9.75
  • Analyst Decision
  • SAGE Hold
  • METC Strong Buy
  • Analyst Count
  • SAGE 20
  • METC 3
  • Target Price
  • SAGE $10.67
  • METC $17.00
  • AVG Volume (30 Days)
  • SAGE 1.8M
  • METC 488.1K
  • Earning Date
  • SAGE 02-11-2025
  • METC 03-06-2025
  • Dividend Yield
  • SAGE N/A
  • METC 5.64%
  • EPS Growth
  • SAGE N/A
  • METC N/A
  • EPS
  • SAGE N/A
  • METC 0.71
  • Revenue
  • SAGE $41,243,000.00
  • METC $698,132,000.00
  • Revenue This Year
  • SAGE $123.13
  • METC N/A
  • Revenue Next Year
  • SAGE $69.65
  • METC $21.02
  • P/E Ratio
  • SAGE N/A
  • METC $13.66
  • Revenue Growth
  • SAGE N/A
  • METC 11.52
  • 52 Week Low
  • SAGE $4.62
  • METC $8.87
  • 52 Week High
  • SAGE $23.22
  • METC $20.50
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 60.55
  • METC 46.72
  • Support Level
  • SAGE $7.00
  • METC $9.20
  • Resistance Level
  • SAGE $7.26
  • METC $10.20
  • Average True Range (ATR)
  • SAGE 0.19
  • METC 0.53
  • MACD
  • SAGE -0.06
  • METC 0.01
  • Stochastic Oscillator
  • SAGE 57.14
  • METC 33.54

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves and resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mill and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

Share on Social Networks: